Poliquin writes to FDA about pharmaceutical electronic information

Congressman Bruce Poliquin recently wrote to the United States Food and Drug Administration (FDA) about a rule that could enable pharmaceutical companies to distribute prescription information through electronics rather than through paper. The letter, which he sent to Dr. Margaret Hamburg (Commissioner of the FDA), opposes the idea that the companies should be allowed to electronically send such information to health care professionals. His reasoning is that there are still many families witho Read More »